LFCR
Lifecore Biomedical Inc.
NASDAQ: LFCR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.07
+2.63% today
Updated 2026-04-30
Market cap
$190.38M
P/E ratio
—
P/S ratio
1.47x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$4 – $9
Volume
0.4M
Lifecore Biomedical Inc. (LFCR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |